These findings also propose the possibility of using alternative FOXM1-targeting cytotoxic agents to treat 5-FU-resistant cancer cells that have FOXM1–TYMS regulation uncoupled and lower FOXM1 expression. The gene discussed is FOXM1; the disease is cancer.